MRI-derived proton density fat fraction.

Reflecting the growing interest in early diagnosis of nonalcoholic fatty liver disease in recent years, the development of noninvasive and reliable fat quantification methods is required. Fat quantification by magnetic resonance imaging (MRI), especially MRI-derived proton density fat fraction (MRI-PDFF) obtained by quantitative chemical shift imaging such as the multi-point Dixon method, is highly correlated with histological evaluation and fat quantification with MR spectroscopy (MRS). In recent years, MRI-PDFF has been increasingly used as a reference standard for image-based fat quantification instead of MRS because it is possible to evaluate the whole liver with a single breath-hold. Furthermore, recent advances in MR imaging have led to the application of multiparametric MRI for the diagnosis of nonalcoholic fatty liver disease with specific liver tissue quantification of fat, iron, and fibrosis. One of the advantages of multiparametric MRI is that whole organ imaging to exclude sampling variability and organ-specific tissue quantification can be done simultaneously. Therefore, multiparametric MRI methods offer an attractive option for noninvasive and comprehensive liver assessment beyond the quantitative assessment of liver steatosis. In this review article, we mainly focus on a technical explanation and clinical interpretation of MRI-PDFF in the quantitative assessment of liver steatosis. Furthermore, we would like to mention future perspectives of MR imaging of the liver in relation to elastography and other specific multiparametric MRI methods such as R2* and T1 mapping.

Quantitative assessment of liver steatosis using ultrasound: dual-energy CT.

Reflecting the growing interest in early diagnosis of non-alcoholic fatty liver disease in recent years, the development of noninvasive and reliable fat quantification methods is needed. Dual-energy computed tomography (DE-CT) is a quantitative diagnostic imaging method that estimates the composition of the imaging target using a material decomposition technique based on the X-ray absorption characteristics peculiar to substances from DE-CT scanning using X-rays generated with different energies (tube voltage). In this review article, we first explain the basic principles and technical aspects of DE-CT. Then, we will present the current diagnostic ability of DE-CT and the factors influencing the quantitative evaluation of liver steatosis using DE-CT as compared to multi-modal methods including ultrasound and magnetic resonance imaging-based methods. In brief, DE-CT may have comparable diagnostic performance to the modern US-based liver fat measurement methods. However, the current material decomposition technique using DE-CT does not seem to have added value to the simple quantitative assessment of liver steatosis, because DE-CT measurement does not improve the accuracy of fat quantification over conventional single-energy computed tomography (SE-CT) attenuation. The most significant influencing factor for the quantitative assessment of liver steatosis using DE-CT can be hepatic iron deposition. An iron-specific multi-material decomposition algorithm correcting for the influences of iron in the liver has been under development. The current material decomposition algorithm can still have added value in a specific situation such as the quantitative assessment of liver steatosis using contrast-enhanced DE-CT. However, there is a lack of evidence for the influence of liver fibrosis in the quantitative assessment of liver steatosis using DE-CT.

Dynamic contrast-enhanced computed tomography diagnosis of primary liver cancers using transfer learning of pretrained convolutional neural networks: Is registration of multiphasic images necessary?

PURPOSE: To evaluate the effect of image registration on the diagnostic performance of transfer learning (TL) using pretrained convolutional neural networks (CNNs) and three-phasic dynamic contrast-enhanced computed tomography (DCE-CT) for primary liver cancers. METHODS: We retrospectively evaluated 215 consecutive patients with histologically proven primary liver cancers, including six early, 58 well-differentiated, 109 moderately differentiated, 29 poorly differentiated hepatocellular carcinomas (HCCs), and 13 non-HCC malignant lesions containing cholangiocellular components. We performed TL using various pretrained CNNs and preoperative three-phasic DCE-CT images. Three-phasic DCE-CT images were manually registered to correct respiratory motion. The registered DCE-CT images were then assigned to the three color channels of an input image for TL: pre-contrast, early phase, and delayed phase images for the blue, red, and green channels, respectively. To evaluate the effects of image registration, the registered input image was intentionally misaligned in the three color channels by pixel shifts, rotations, and skews with various degrees. The diagnostic performances (DP) of the pretrained CNNs after TL in the test set were compared by three general radiologists (GRs) and two experienced abdominal radiologists (ARs). The effects of misalignment in the input image and the type of pretrained CNN on the DP were statistically evaluated. RESULTS: The mean DPs for histological subtype classification and differentiation in primary malignant liver tumors on DCE-CT for GR and AR were 39.1%, and 47.9%, respectively. The highest mean DPs for CNNs after TL with pixel shifts, rotations, and skew misalignments were 44.1%, 44.2%, and 43.7%, respectively. Two-way analysis of variance revealed that the DP is significantly affected by the type of pretrained CNN (P = 0.0001), but not by misalignments in input images other than skew deformations. CONCLUSION: TL using pretrained CNNs is robust against misregistration of multiphasic images and comparable to experienced ARs in classifying primary liver cancers using three-phasic DCE-CT.

Improvement in radiological reading efficiency and residents' education and clinical contribution using the modified reading system "Triage Reader".

PURPOSE: To assess whether the modified reading system "Triage Reader" (TR) can improve the radiological reading work environment. MATERIALS AND METHODS: This retrospective, single-center study analyzed two reading systems for 26,786 computed tomography and magnetic resonance imaging examinations. In the conventional system (January 1-May 31, 2016), all reading work was mostly completed within the day. In the TR system (January 1-May 31, 2017), a radiology resident (TR) first read every image immediately after the examination and tagged each examination according to actual image findings and clinical demands. Routine reading work was finished when all high-priority cases were completed. Low-priority cases were assessed the following day. RESULTS: When using the TR system, the mean reading number in the evening decreased (P = 0.009). The mean elapsed time to finalize report of case with actual urgent image finding shortened from 4.26 to 1.97 h (P < 0.0001). The mean number of cases experienced per resident increased from 5.4 to 28.7 (P < 0.001). Subjective evaluation revealed a significant improvement in "Reading efficiency" and "Contribution to clinical practice." CONCLUSION: Introduction of the TR system can improve the reading efficiency and quality, educational effect among residents by increasing the number of experienced cases and work satisfaction.

Outcomes of uterine cervical cancer patients with pelvic lymph node metastases after radiotherapy without boost irradiation of metastases.

AIM: The aim of this study was to evaluate the outcomes of uterine cervical cancer patients with pelvic lymph node (PLN) metastases after radiotherapy without boost irradiation of the metastases and to clarify the necessity of the boost irradiation of metastatic lesions. METHODS: Thirty-two patients with uterine cervical cancer metastasizing only to the PLN were treated with definitive radiotherapy without boost irradiation of the metastases between 2008 and 2012 at our institution and were selected for this study. The pattern of progression, overall survival, and progression-free survival were analyzed. RESULTS: Ninety percent of the PLN metastases were controlled by radiotherapy. Twenty-two of 32 patients (69%) experienced progression. Distant metastases as initial progression were observed in 21 of these 22 patients (95%). Only two patients experienced failures in pre-treatment metastatic PLN as initial progression, along with other failures. Severe late lower gastrointestinal toxicities were not observed in any patients. Two-year cumulative overall survival and progression-free survival were 74% and 31%, respectively. CONCLUSION: Boost irradiation of PLN metastases is not necessarily indispensable. Further studies to examine the necessity of boost irradiation of PLN metastases in radiotherapy for uterine cervical cancer patients with metastases are required.

Palliative radiotherapy for Japanese patients with malignant melanoma: a single-institution experience.

PURPOSE: This study aimed to clarify the significance of palliative radiotherapy for Japanese patients with malignant melanoma based on the experience of our institution. MATERIALS AND METHODS: Twenty-nine patients with malignant melanoma who underwent palliative radiotherapy at our facility were included in the investigation. Median radiation dose was 30 Gy (4-30). RESULTS: Median follow-up time was 4.2 months (range 2.7-40.5 months). Twenty-two patient (75.9%) died during the follow-up. The response rate of overall symptoms to radiotherapy was 63.0%. The rate of completely resolved hemorrhage was relatively high (81.8%). The median time of freedom from progression in completely resolved symptoms was 3.1 months (range 0.2-27.8 months). Radiation dose <30 Gy and poor performance status tended to be associated with poor symptomatic relief in treatment site (p = .080 and p = .068, respectively). There were very few severe toxic events. CONCLUSION: Two thirds of symptoms were safely alleviated by palliative radiotherapy for Japanese patients with malignant melanoma. The therapeutic effect was retained for a substantial duration. Further domestic studies are warranted.

BPG3 is a novel chloroplast protein that involves the greening of leaves and related to brassinosteroid signaling.

Brassinosteroids are plant steroid hormones that regulate plant organs and chloroplast development. The detailed molecular mechanism for plant development by BR signaling is yet to be revealed, and many points regarding the relationship between BR signaling and chloroplast development remain unknown. We identify here the dominant mutant Brz-insensitive-pale green3-1D (bpg3-1D) from the Arabidopsis FOX lines that show reduced sensitivity to the chlorophyll accumulation promoted by the BR biosynthesis inhibitor, Brassinazole (Brz), in the light. BPG3 encodes a novel chloroplast protein that is evolutionally conserved in bacteria, algae, and higher plants. The expression of BPG3 was induced by light and Brz. The inhibition of electron transport in photosystem II of the chloroplasts was detected in bpg3-1D. These results suggest that BPG3 played an important role in regulating photosynthesis in the chloroplast under BR signaling.

Validity of reduced radiation dose for localized diffuse large B-cell lymphoma showing a good response to chemotherapy.

To evaluate the validity of a decrease in the radiation dose for patients who were good responders to chemotherapy for localized diffuse large B-cell lymphoma (DLBCL), 91 patients with localized DLBCL who underwent radiotherapy after multi-agent chemotherapy from 1988-2008 were reviewed. Exclusion criteria were as follows: central nervous system or nasal cavity primary site, or Stage II with bulky tumor (≥10 cm). Of these patients, 62 were identified as good responders to chemotherapy. They were divided into two groups receiving either a higher or a lower radiation dose (32-50.4 Gy or 15-30.6 Gy, respectively). There were no statistically significant differences between the lower and higher dose groups in progression-free survival, locoregional progression-free survival or overall survival. Adaptation of decreased radiation dose may be valid for localized DLBCL patients who show a good response to chemotherapy.